
Bio Rad Laboratories Inc
NYSE:BIO

Intrinsic Value
The intrinsic value of one
BIO
stock under the Base Case scenario is
349.95
USD.
Compared to the current market price of 229.13 USD,
Bio Rad Laboratories Inc
is
Undervalued by 35%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Bio Rad Laboratories Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Bio Rad Laboratories Inc
Balance Sheet Decomposition
Bio Rad Laboratories Inc
Current Assets | 3B |
Cash & Short-Term Investments | 1.7B |
Receivables | 425m |
Other Current Assets | 951.6m |
Non-Current Assets | 6.5B |
Long-Term Investments | 5B |
PP&E | 682m |
Intangibles | 711m |
Other Non-Current Assets | 103m |
Free Cash Flow Analysis
Bio Rad Laboratories Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Bio Rad Laboratories Inc
Revenue
|
2.5B
USD
|
Cost of Revenue
|
-1.2B
USD
|
Gross Profit
|
1.4B
USD
|
Operating Expenses
|
-1.1B
USD
|
Operating Income
|
308.6m
USD
|
Other Expenses
|
-2.5B
USD
|
Net Income
|
-2.2B
USD
|
BIO Profitability Score
Profitability Due Diligence
Bio Rad Laboratories Inc's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

Score
Bio Rad Laboratories Inc's profitability score is 39/100. The higher the profitability score, the more profitable the company is.
BIO Solvency Score
Solvency Due Diligence
Bio Rad Laboratories Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Score
Bio Rad Laboratories Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BIO Price Targets Summary
Bio Rad Laboratories Inc
According to Wall Street analysts, the average 1-year price target for
BIO
is 324.19 USD
with a low forecast of 262.6 USD and a high forecast of 411.6 USD.
Dividends
Current shareholder yield for BIO is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
BIO
stock under the Base Case scenario is
349.95
USD.
Compared to the current market price of 229.13 USD,
Bio Rad Laboratories Inc
is
Undervalued by 35%.